Hypertension guideline update: A new guideline for a new era.

JAAPA

Sondra M. DePalma practices at PinnacleHealth CardioVascular Institute in Harrisburg, Pa., and is director of regulatory and professional practice for the American Academy of PAs in Alexandria, Va. Cheryl Dennison Himmelfarb is a professor and associate dean for research at Johns Hopkins University School of Nursing in Baltimore, Md. Eric J. MacLaughlin is a professor and chair of the Department of Pharmacy Practice at Texas Tech University Health Sciences Center's School of Pharmacy in Amarillo, Tex. Sandra J. Taler is a staff consultant in the Division of Nephrology/Hypertension and a professor of medicine at the Mayo Clinic College of Medicine in Rochester, Minn. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Published: June 2018

In the United States, hypertension affects about one-third of adults and contributes to one out of every seven deaths. Evidence-based treatment is associated with reductions in incidence of stroke, myocardial infarction, and heart failure as well as associated disability and death. This article reviews the ACC/AHA Task Force on Clinical Practice Guidelines' 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Key changes include reclassification of BP stages and lowering of hypertension treatment goals.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JAA.0000533656.93911.38DOI Listing

Publication Analysis

Top Keywords

hypertension guideline
4
guideline update
4
update guideline
4
guideline era
4
era united
4
united states
4
states hypertension
4
hypertension one-third
4
one-third adults
4
adults contributes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!